The Role of SIRT1 in Diabetic Kidney Disease

Overview

Journal Front Endocrinol (Lausanne)

Specialty Endocrinology

Date 2014 Oct 28

PMID 25346724

Citations 48

Authors

Rabi Yacoub

Kyung Lee

John Cijiang He

Affiliations

Soon will be listed here.

Abstract

Sirtuins (SIRTs) are members of the silent information regulator 2 family. In mammals, of the seven known SIRTs, SIRT1 function is most studied and has been shown to regulate wide range of cellular functions that affect metabolic homeostasis and aging. SIRT1 exerts anti-apoptotic, anti-oxidative, and anti-inflammatory effects against cellular injury, and protects the cells through the regulation of mitochondrial biogenesis, autophagy, and metabolism in response to the cellular energy and redox status. SIRT1 also promotes vasodilation and protects vascular tissues. In humans and animal models with diabetic kidney disease (DKD), its expression tends to be decreased in renal cells, and increased expression of SIRT1 was found to play a renal protective role in animal models with DKD. In this review, we discuss the role and potential mechanisms by which SIRT1 protects against DKD.

Citing Articles

LncRNA LYPLAL1, miR-204-5p, and SIRT1: novel signatures for risk assessment of diabetic macrovascular complications.

Mobasher M, Shabana M, Germoush M, Abuzinadah N, Abd-Elhameed A, Baioumy S Sci Rep. 2024; 14(1):24154.

PMID: 39406930 PMC: 11480381. DOI: 10.1038/s41598-024-75543-6.

Oxidative stress and senescence in aging kidneys: the protective role of SIRT1.

Almalki W, Salman Almujri S EXCLI J. 2024; 23:1030-1067.

PMID: 39391060 PMC: 11464868. DOI: 10.17179/excli2024-7519.

Mechanisms of hepatic and renal injury in lipid metabolism disorders in metabolic syndrome.

Rong J, Zhang Z, Peng X, Li P, Zhao T, Zhong Y Int J Biol Sci. 2024; 20(12):4783-4798.

PMID: 39309427 PMC: 11414397. DOI: 10.7150/ijbs.100394.

Whole patient knowledge modeling of COVID-19 symptomatology reveals common molecular mechanisms.

Brock S, Jackson D, Soldatos T, Hornischer K, Schafer A, Diella F Front Mol Med. 2024; 2:1035290.

PMID: 39086962 PMC: 11285600. DOI: 10.3389/fmmed.2022.1035290.

LRG1 loss effectively restrains glomerular TGF-β signaling to attenuate diabetic kidney disease.

Wang X, Sun Z, Fu J, Fang Z, Zhang W, He J Mol Ther. 2024; 32(9):3177-3193.

PMID: 38910328 PMC: 11403230. DOI: 10.1016/j.ymthe.2024.06.027.

References

Wu L, Zhang Y, Ma X, Zhang N, Qin G . The effect of resveratrol on FoxO1 expression in kidneys of diabetic nephropathy rats. Mol Biol Rep. 2012; 39(9):9085-93. DOI: 10.1007/s11033-012-1780-z. View

Lee I, Cao L, Mostoslavsky R, Lombard D, Liu J, Bruns N . A role for the NAD-dependent deacetylase Sirt1 in the regulation of autophagy. Proc Natl Acad Sci U S A. 2008; 105(9):3374-9. PMC: 2265142. DOI: 10.1073/pnas.0712145105. View

Inoue Y, Itoh Y, Abe K, Okamoto T, Daitoku H, Fukamizu A . Smad3 is acetylated by p300/CBP to regulate its transactivation activity. Oncogene. 2006; 26(4):500-8. DOI: 10.1038/sj.onc.1209826. View

Inzucchi S, Bergenstal R, Buse J, Diamant M, Ferrannini E, Nauck M . Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care. 2012; 35(6):1364-79. PMC: 3357214. DOI: 10.2337/dc12-0413. View

Zhuo L, Fu B, Bai X, Zhang B, Wu L, Cui J . NAD blocks high glucose induced mesangial hypertrophy via activation of the sirtuins-AMPK-mTOR pathway. Cell Physiol Biochem. 2011; 27(6):681-90. DOI: 10.1159/000330077. View

Li J, Qu X, Ricardo S, Bertram J, Nikolic-Paterson D . Resveratrol inhibits renal fibrosis in the obstructed kidney: potential role in deacetylation of Smad3. Am J Pathol. 2010; 177(3):1065-71. PMC: 2928940. DOI: 10.2353/ajpath.2010.090923. View

Purushotham A, Schug T, Xu Q, Surapureddi S, Guo X, Li X . Hepatocyte-specific deletion of SIRT1 alters fatty acid metabolism and results in hepatic steatosis and inflammation. Cell Metab. 2009; 9(4):327-38. PMC: 2668535. DOI: 10.1016/j.cmet.2009.02.006. View

Mortuza R, Chen S, Feng B, Sen S, Chakrabarti S . High glucose induced alteration of SIRTs in endothelial cells causes rapid aging in a p300 and FOXO regulated pathway. PLoS One. 2013; 8(1):e54514. PMC: 3546959. DOI: 10.1371/journal.pone.0054514. View

Guarente L . Sir2 links chromatin silencing, metabolism, and aging. Genes Dev. 2000; 14(9):1021-6. View

10.

Eid A, Gorin Y, Fagg B, Maalouf R, Barnes J, Block K . Mechanisms of podocyte injury in diabetes: role of cytochrome P450 and NADPH oxidases. Diabetes. 2009; 58(5):1201-11. PMC: 2671039. DOI: 10.2337/db08-1536. View

11.

Hohenstein B, Hausknecht B, Boehmer K, Riess R, Brekken R, Hugo C . Local VEGF activity but not VEGF expression is tightly regulated during diabetic nephropathy in man. Kidney Int. 2006; 69(9):1654-61. DOI: 10.1038/sj.ki.5000294. View

12.

Chuang P, Dai Y, Liu R, He H, Kretzler M, Jim B . Alteration of forkhead box O (foxo4) acetylation mediates apoptosis of podocytes in diabetes mellitus. PLoS One. 2011; 6(8):e23566. PMC: 3157434. DOI: 10.1371/journal.pone.0023566. View

13.

Danaei G, Finucane M, Lu Y, Singh G, Cowan M, Paciorek C . National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2·7 million participants. Lancet. 2011; 378(9785):31-40. DOI: 10.1016/S0140-6736(11)60679-X. View

14.

Zhou S, Chen H, Wan Y, Zhang Q, Wei Y, Huang S . Repression of P66Shc expression by SIRT1 contributes to the prevention of hyperglycemia-induced endothelial dysfunction. Circ Res. 2011; 109(6):639-48. DOI: 10.1161/CIRCRESAHA.111.243592. View

15.

Nihalani D, Susztak K . Sirt1-Claudin-1 crosstalk regulates renal function. Nat Med. 2013; 19(11):1371-2. DOI: 10.1038/nm.3386. View

16.

Lagouge M, Argmann C, Gerhart-Hines Z, Meziane H, Lerin C, Daussin F . Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha. Cell. 2006; 127(6):1109-22. DOI: 10.1016/j.cell.2006.11.013. View

17.

Brezis M, Rosen S . Hypoxia of the renal medulla--its implications for disease. N Engl J Med. 1995; 332(10):647-55. DOI: 10.1056/NEJM199503093321006. View

18.

Matsusaka T, Sandgren E, Shintani A, Kon V, Pastan I, Fogo A . Podocyte injury damages other podocytes. J Am Soc Nephrol. 2011; 22(7):1275-85. PMC: 3137575. DOI: 10.1681/ASN.2010090963. View

19.

Sun C, Zhang F, Ge X, Yan T, Chen X, Shi X . SIRT1 improves insulin sensitivity under insulin-resistant conditions by repressing PTP1B. Cell Metab. 2007; 6(4):307-19. DOI: 10.1016/j.cmet.2007.08.014. View

20.

Maisonpierre P, Suri C, Jones P, Bartunkova S, Wiegand S, Radziejewski C . Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science. 1997; 277(5322):55-60. DOI: 10.1126/science.277.5322.55. View